Dermatotropic agents for combined treatment of psoriasis

Filimonkova N.N.; Kashcheeva Ia.V.; Chuverova K.A.

doi:https://doi.org/

Filimonkova N.N.

Ural Research Institute of Dermatovenerology and Immunopathology, Ekaterinburg

Kashcheeva Ia.V.

Ural Research Institute of Dermatovenerology and Immunopathology, Ekaterinburg

Chuverova K.A.

Ural Research Institute of Dermatovenerology and Immunopathology, Ekaterinburg

Dermatotropic agents for combined treatment of psoriasis

Authors:

Filimonkova N.N., Kashcheeva Ia.V., Chuverova K.A.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2010;8(1): 35‑38

Read: 5524 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Filimonkova NN, Kashcheeva IaV, Chuverova KA. Dermatotropic agents for combined treatment of psoriasis. Russian Journal of Clinical Dermatology and Venereology. 2010;8(1):35‑38. (In Russ.)

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

New approach to clinical evaluation of nail lesions in psoriasis. Russian Journal of Clinical Dermatology and Venereology. 2025;(4):453-460

Abstract:

Keywords:

divobet

psoriatic erythrodermia

pustular psoriasis

psoriatic onychodystropia

PASI and DLQI index

Authors:

Filimonkova N.N.

Ural Research Institute of Dermatovenerology and Immunopathology, Ekaterinburg

Kashcheeva Ia.V.

Ural Research Institute of Dermatovenerology and Immunopathology, Ekaterinburg

Chuverova K.A.

Ural Research Institute of Dermatovenerology and Immunopathology, Ekaterinburg

Close metadata

References:

Katunina O.R. Immunnaya sistema kozhi i ee rol' v lechenii psoriaza. Vestn dermatol i venerol 2005; 1: 19-23.
Christophers E. Psoriasis - epidemiology and clinical spectrum. Clin Exp Dermatol 2001; 26: 4: 314-320.
Kungurov N.V., Filimonkova N.N., Tuzankina I.A. Psoriaticheskaya bolezn'. Ekaterinburg 2002; 193.
Nickoloff B.J., Nestle F.O. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 2004; 15: 1664-1675.
Schön M.P., Boehncke W.H. Psoriasis. N Engl J Med 2005; 352: 18: 1899-1912.
Mordovtsev V.N., Mushet G.V., Al'banova V.I. Psoriaz. Patogenez, klinika, lechenie. Kishinev 1991; 186.
Kubanova A.A. Klinicheskie rekomendatsii. Dermatovenerologiya. M 2007; 300.
Krueger J.G., Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64: 30-36.
Al-Mutairi N., Manchanda Y., Noir-Eldin O. Nail changes in childhood psoriasis- a study from Kuwait. Pediat Dermatol 2007; 24; 1: 7-10.
Filimonkova N.N., Chuverova K.A., Letaeva O.V., Yan I.A. Kompleksnaya terapiya bol'nykh psoriazom preparatami «Daivobet» i «Daivoneks». Vrach 2008; 1: 33-36.
Giannetti A., Coppini M., Baggio A. A new stable association of calcipotriol and betamethasone dipropionate for the topical treatment of psoriasis: a clinical experience. Dermatol Exp 2005; 7: 53-59.
van de Kerkof P.C.M., Wasel N., Kragballe K. et al. A two-compound product containing calcipotriol and betamethasone dipropionate provides rapid, effective treatment of psoriasis vulgaris regardless of baseline disease severity. Dermatology 2005; 210: 294-299.